Mylan has already issued a recall on several lots previous to Friday's announcement, but said they expanded it out of an abundance of caution.
It says EpiPens distributed between January and March of previous year and EpiPen Juniors from November 2015 to February 2016 were affected.
The defect makes it hard for the EpiPen to work during an emergency and could have significant health consequences for someone who is experiencing an allergic reaction. The incidence of the defect is extremely rare and testing and analysis across the potentially impacted lots has not identified any units with a defect.
Mylan NV announced that the additional recalled items were part of 13 lots of EpiPen (0.3 mg) and EpiPen Jr.
Note that the recall does not include the generic version of the auto-injector released by Mylan in late 2016.More news: Gov't Watchdog To Examine Cost Of Trump's Trips To Mar-A-Lago
Consumers should contact Mylan at 800-796-9526 or email@example.com with questions.
Mylan will replace recalled EpiPens for no additional costs.
Rather than discard the recalled EpiPens, Mylan is suggesting that patients who have one of the devices on the above list to hold onto their injector until they have secured a replacement.
EpiPens deliver an emergency dose of adrenaline to people at risk of a serious allergic reaction.